Abstract
ASSESSMENT OF POLYPHARMACY AND ASSOCIATED PROBLEMS IN CARDIO VASCULAR DISEASED PATIENTS IN A SECONDARY CARE HOSPITAL

Immanuel Jebastine*, Sudhakar. R, Hemalatha. S and Apollo James

ABSTRACT

Background: Polypharmacy is a major public health problem among the hospitalized patients. The prescription of multiple medications leads to polypharmacy, adverse drug reactions, drug-drug interactions and non-adherence to treatment. Objective: The present study was designed to analyze the polypharmacy in patients with cardiovascular disease and associated problems like drug-drug interactions, drug duplication and adverse drug reactions in patients prescribed with polypharmacy. Methodology: A prospective observational study was performed in secondary care hospital of cardiovascular department in Salem, Tamilnadu, India. Only patients prescribed with polypharmacy were included in our study. Results: A total of 140 cardiovascular patients were analyzed in which 65.72% of patients were male and 34.28% of patients were females. The major fraction 54% of the patients was in the age group of 61-80 years and 30% of the patients aged above 80 years. The prevalence of polypharmacy is more common in male 61.0% and 38.9% in females. In a study group 46.42% population has coronary artery disease and 13.57% had rheumatic heart disease. Polypharmacy was observed in almost all cases, wherein 14.29% were prescribed more than 16 drugs, 17.86% of patients were with 13-16 drugs, 35.71% of patients were with 9-12 drugs and 32.14% were with 5-8 drugs. Anti-coagulants are most commonly prescribed drugs 64.2% followed by 51.41% prescribed with anti-platelet drugs. Micromedix and Medscape drug interaction checker was used to analyze the drug interaction. A total of 32 potent drug interactions were found and 25 ADR were found during our study. Conclusion: Results of the study revealed that polypharmacy is a major cause for drug-drug interaction and adverse drug reactions in cardiovascular patients. The clinical pharmacist should address the valuable services to minimize drug-interactions and ADR due to polypharmacy.

Keywords: polypharmacy, drug-drug interaction, adverse drug interaction, drug duplications.


[Full Text Article]

Login





Forgot Password  |  Register

Indexing

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation

  • EJBPS: FEBRUARY ISSUE PUBLISHED

    FEBRUARY 2023 Issue has been successfully launched on 1 FEBRUARY 2023.

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT